Clinical Trials Directory

Trials / Completed

CompletedNCT03094546

Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline

Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function and Biomarkers in Elderly Individuals With Subjective Cognitive Decline

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Accepted

Summary

The overall objective of this study is to examine the effect of polyamine supplementation on cognitive performance and further characterization of individuals with subjective cognitive decline.

Detailed description

Memory abilities are known to decline during aging, a process that is accelerated in pathological conditions like mild cognitive impairment (MCI) and Alzheimer's disease (AD), all of which are a growing public-health concern with devastating social and economical effects. Polyamines supplementation and corresponding up-regulation of autophagy (i.e., cellular protein degradation pathways) may be a key target of intervention against age-related memory decline. The study will investigate whether a polyamine-enriched dietary supplementation (through capsule intake) could provide positive effects on cognitive function and biomarkers of elderly individuals (60-90 years old) with subjective cognitive decline (SCD).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolyamine12 months of polyamine supplementation (6 capsules/day)
DIETARY_SUPPLEMENTPlacebo12 months of placebo intake (6 capsules/day)

Timeline

Start date
2017-01-01
Primary completion
2020-05-01
Completion
2020-10-01
First posted
2017-03-29
Last updated
2021-04-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03094546. Inclusion in this directory is not an endorsement.